- Business
- Learn about emerging longevity therapies and the innovation driving the anti-aging sector.
- Everyday users
- Discover potential future treatments for extending healthspan and lifespan, and Sinclair's personal health strategies.
Features a prominent researcher discussing significant advancements in longevity and age reversal.
David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250
Audio streams from PHD Ventures. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
Peter Diamandis interviews Dr. David Sinclair on Moonshots about longevity research. They discuss epigenetic reprogramming, extending human lifespan, and accessible therapies. Sinclair shares his personal protocols and the future of anti-aging science, highlighting innovation and community support. The episode was filmed at the 2026 Abundance360 Summit.
This episode discusses how scientists are trying to slow down or even reverse aging. Dr. David Sinclair explains new ways to understand and potentially treat aging, which could help people live healthier for longer.
This episode offers insights into the cutting edge of longevity science from a leading researcher. Listeners will learn about potential age reversal technologies and Sinclair's personal health strategies. It is for anyone interested in healthspan and lifespan extension. While not directly about AI models, the rapid progress in understanding biological systems and developing interventions shares a spirit of exponential advancement seen in AI research by labs like Google Gemini and OpenAI.
- HostPeter Diamandis
- GuestDavid SinclairProfessor of Genetics, Harvard Medical School
- Guest: Dr. David Sinclair
- Title: David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250
- Show: Moonshots with Peter Diamandis
- Length: 33 minutes
- Filming Location: 2026 Abundance360 Summit
- Guest Affiliation: Professor of Genetics at Harvard Medical School
This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/
In this insightful interview, Dr. David Sinclair discusses groundbreaking advancements in longevity research, including epigenetic reprogramming trials, the potential for extending human lifespan, and accessible therapies. He shares his personal protocols and the future of anti-aging science, emphasizing the importance of innovation and community support.
Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends
David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur.
Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360
–
My companies:
Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding
Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy
Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter
_
Connect with Peter:
Connect with David
Listen to MOONSHOTS:
–
*Recorded on March 9th, 2026
*The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice.
Learn more about your ad choices. Visit megaphone.fm/adchoices
- epigenetic reprogramming
- Dr. David Sinclair
- Changing how genes are used without altering the DNA sequence itself, potentially reversing aging effects.
Flying Tesla Car, Robot Brains Halving in Cost Every 3 Weeks, and Why Incentives Decide AI Alignment | #303
WithAnousheh Ansari, Salim Ismail, Emad Mostaque
Same guests, other shows
The AI Models Smart Enough to Know They're Cheating — Beth Barnes & David Rein [METR]
WithBeth Barnes, David Rein
Dara Khosrowshahi on replacing Uber drivers — and himself — with AI
WithDara Khosrowshahi
Questions people ask
- Where was this episode filmed?
- This episode was filmed at the 2026 Abundance360 Summit.
- Who is David Sinclair?
- David A. Sinclair is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to PHD Ventures.




